Federated Multi-Omics Integration

Aligns data from the same patient cohort across institutions where each holds a different omics layer (e.g., Hospital A has genomics, Hospital B has proteomics). Uses entity resolution to match patient records without revealing identities, then trains split neural networks where each party learns representations of its own modality. A central server aggregates only the inter-modal interaction gradients, enabling joint inference across molecular layers that never physically colocate.

Employs architectures like multi-modal autoencoders and contrastive learning to project heterogeneous omics data into a shared latent space. Key techniques include:

• CCA-based alignment: Canonical correlation analysis to maximize shared variance
• Adversarial domain adaptation: Aligning distributions across modalities without paired samples
• Transformer-based fusion: Cross-attention between genomic and proteomic embeddings The result is a unified biological representation learned without any single institution accessing all data layers.

Extends federated genome-wide association studies to incorporate transcriptomic and epigenomic covariates. Each site computes local summary statistics for genotype-phenotype associations while adjusting for gene expression levels and methylation states held at other sites. Secure aggregation protocols combine these partial results, dramatically increasing statistical power to detect expression quantitative trait loci (eQTLs) and methylation QTLs across distributed cohorts.

Implements decentralized Cox proportional hazards and deep survival networks that ingest genomics, transcriptomics, and clinical features from separate institutions. Each site trains on its local omics layer, sharing only log-partial likelihood gradients. The global model learns to weight the prognostic contribution of each molecular layer—identifying, for example, that a specific gene expression signature from Site B modifies the risk conferred by a germline variant at Site A.

Addresses the fundamental challenge where omics layers are inherently non-IID across sites—not just in sample distribution but in feature space. Techniques include:

• Modality dropout: Randomly omitting entire omics layers during training to prevent over-reliance on any single modality
• Federated domain generalization: Learning invariances across site-specific batch effects and assay platforms
• Personalized fusion heads: Site-specific aggregation layers that adapt global representations to local modality availability

Uses decentralized conditional generative adversarial networks (GANs) and variational autoencoders (VAEs) to generate artificial multi-omics profiles. Each institution trains a local generator conditioned on its omics layer; a federated discriminator ensures synthetic samples preserve cross-modal correlations without exposing real data. The resulting synthetic cohorts enable downstream analysis, biomarker discovery, and model validation across the full molecular landscape while maintaining differential privacy guarantees.

A critical challenge in federated multi-omics where local datasets are not independently and identically distributed. This manifests as:

• Label skew: Different hospitals have different disease prevalences.
• Feature skew: Different sequencing platforms produce varying read depths.
• Concept drift: The same mutation may have different clinical significance across populations. Non-IID data severely degrades the convergence of standard Federated Averaging, requiring specialized optimization strategies.